Search alternatives:
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
larger increases » large increases (Expand Search), marked increases (Expand Search), larger decrease (Expand Search)
b largest » _ largest (Expand Search)
via large » a large (Expand Search)
ai larger » ai large (Expand Search), a large (Expand Search), _ larger (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
largest decrease » largest decreases (Expand Search), larger decrease (Expand Search), marked decrease (Expand Search)
larger increases » large increases (Expand Search), marked increases (Expand Search), larger decrease (Expand Search)
b largest » _ largest (Expand Search)
via large » a large (Expand Search)
ai larger » ai large (Expand Search), a large (Expand Search), _ larger (Expand Search)
b large » _ large (Expand Search), a large (Expand Search), i large (Expand Search)
-
81
-
82
-
83
-
84
The effects of siARG2 or siRGS4 on AdNKX2-1-induced cell death, apoptosis, and necrosis.
Published 2021Subjects: -
85
-
86
Apoptosis and necrosis detection in BHP18-21v cells after adenoviral vector infection.
Published 2021Subjects: -
87
ARG2 and RGS4 expression in siRNA-transfected cells after AdNKX2-1 infection.
Published 2021Subjects: -
88
-
89
-
90
-
91
Table4_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
92
Table3_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
93
Table6_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
94
Table1_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.DOCX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
95
Table2_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
96
Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX
Published 2022“…<p>Background: Diffuse large B-cell lymphoma (DLBCL) is the most common aggressive lymphoma with an increased tendency to relapse or refractoriness. …”
-
97
-
98
-
99
-
100
Data_Sheet_1_Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.docx
Published 2020“…<p>Background: Primary bone B-cell lymphoma (PB-DLBCL) is a rare entity for which existing data is limited. …”